DR. REDDY'S LABORATORIES LIMITED

šŸ‡±šŸ‡°Sri Lanka
Ownership
-
Employees
-
Market Cap
-
Website

Bioequivalence Study of Fexofenadine Hydrochloride Orally Disintegrated Tablets 30 mg Under Fasting Condition

Phase 1
Completed
Conditions
Interventions
First Posted Date
2013-06-28
Last Posted Date
2013-06-28
Lead Sponsor
Dr. Reddy's Laboratories Limited
Target Recruit Count
80
Registration Number
NCT01888718
Locations
šŸ‡®šŸ‡³

Bioserve Clinical Research Private Limited, Balanagar, Hyderabad, Andhra Pradesh, India

Bioequivalence Study of Isotretinoin Capsules 40 mg Under Fasting Condition

Phase 1
Completed
Conditions
Interventions
First Posted Date
2013-06-27
Last Posted Date
2013-06-27
Lead Sponsor
Dr. Reddy's Laboratories Limited
Target Recruit Count
35
Registration Number
NCT01888289
Locations
šŸ‡ŗšŸ‡ø

AAI, Quadrangle Drive, Chapel Hill,, North Carolina, United States

Bioavailability Study of Isotretinoin Capsules 40 mg Under Fed Condition

Phase 1
Completed
Conditions
Interventions
First Posted Date
2013-06-27
Last Posted Date
2013-06-27
Lead Sponsor
Dr. Reddy's Laboratories Limited
Target Recruit Count
61
Registration Number
NCT01888224
Locations
šŸ‡®šŸ‡³

Lambda Therapeutic Research Ltd.,, Ahmedabad, Gujarat, India

Bioequivalence Study of Isotretinoin Capsules 20 mg Under Fasting Condition

Phase 1
Completed
Conditions
Interventions
First Posted Date
2013-06-27
Last Posted Date
2013-06-27
Lead Sponsor
Dr. Reddy's Laboratories Limited
Target Recruit Count
41
Registration Number
NCT01888341
Locations
šŸ‡ŗšŸ‡ø

AAI, Quadrangle Drive, Chapel Hill,, North Carolina, United States

Bioequivalence Study of Lamotrigine Extended-Release Tablets 200mg Under Fasting Condition

Phase 1
Completed
Conditions
Interventions
First Posted Date
2013-06-27
Last Posted Date
2013-06-27
Lead Sponsor
Dr. Reddy's Laboratories Limited
Target Recruit Count
36
Registration Number
NCT01888250
Locations
šŸ‡®šŸ‡³

Bioserve Clinical Research Private Limited, Balanagar, Hyderabad, India

Bioequivalence Study of Isotretinoin Capsules 40 mg Under Fed Condition

Phase 1
Completed
Conditions
Interventions
First Posted Date
2013-06-27
Last Posted Date
2013-06-27
Lead Sponsor
Dr. Reddy's Laboratories Limited
Target Recruit Count
26
Registration Number
NCT01888328
Locations
šŸ‡ŗšŸ‡ø

AAI, Quadrangle Drive, Chapel Hill,, North Carolina, United States

Safety, Efficacy and Tolerability Study of up to 20 mL of DFA-02 in Patients Undergoing Abdominal Surgery

First Posted Date
2013-06-27
Last Posted Date
2016-10-11
Lead Sponsor
Dr. Reddy's Laboratories Limited
Target Recruit Count
445
Registration Number
NCT01888367

Bioequivalence Study of Lamotrigine Extended-Release Tablets 200mg Under Fed Condition

Phase 1
Completed
Conditions
Interventions
First Posted Date
2013-06-27
Last Posted Date
2013-06-27
Lead Sponsor
Dr. Reddy's Laboratories Limited
Target Recruit Count
32
Registration Number
NCT01888263
Locations
šŸ‡®šŸ‡³

Bioserve Clinical Research Private Limited, Balanagar, Hyderabad, India

Bioequivalence Study for Metoprolol Succinate ER Tablets 50 mg Under Fasting Condition

Phase 1
Completed
Conditions
Interventions
First Posted Date
2012-09-27
Last Posted Date
2012-09-28
Lead Sponsor
Dr. Reddy's Laboratories Limited
Target Recruit Count
48
Registration Number
NCT01694797
Locations
šŸ‡®šŸ‡³

Bioserve Clinical Research Private Limited, Hyderabad, Andhra Pradesh, India

Bioequivalence Study of Montelukast Sodium Oral Granules 4mg Under Fed Condition

Phase 1
Completed
Conditions
Interventions
First Posted Date
2012-09-24
Last Posted Date
2012-09-24
Lead Sponsor
Dr. Reddy's Laboratories Limited
Target Recruit Count
31
Registration Number
NCT01691469
Locations
šŸ‡®šŸ‡³

AXIS Clinicals Limited,, Hyderabad, Andhra Pradesh, India

Ā© Copyright 2024. All Rights Reserved by MedPath